Dear EMEUNET members,
As you may already know, EMEUNET started in 2012 a collaboration with Annals of the Rheumatic Diseases (ARD), the official scientific publication of EULARand the top-rankedpeer-reviewed rheumatology journal. Since then, this initiative has been continuously growing and it is a pleasure for us to announce that this edition we will also count with the collaboration of Rheumatic and Musculoskeletal Diseases Open (RMD Open), the open access companion of ARD in EULAR.
This collaboration is in the form of heightening the level of peer-reviewing of EMEUNET members, by allowing them to perform supervised paper reviews. This means that the EMEUNET members will review manuscripts submitted to theseimportant journals under the supervision of senior reviewers who will provide mentoring on the manuscript review process. The coaching process is very important because of the high responsibility of the reviewer due to the highscientific rigor of these journals.
Why areARD and RMD Open Editorial boards interested in involving EMEUNET members?
ARDand RMD Open have increasing number of submissions and thus increasing need for reviewers.Thus, they want to have more trained reviewers available. EMEUNET members are a community of bright young rheumatologists who can contribute to the review process.
Why would you want to participate?
You will (a)receive training on peer reviewing and become a better reviewer; and (b) be in contact with the ARD and RMD Open editorial boards, and with well-known senior reviewers, making the new initiative a win-win opportunity for both, EMEUNET and ARD/RMD Open.
This training provides an outstanding opportunity for the EMEUNET members to become familiar with the state-of-the-art peer-review process and to improve their reviewer skills.
A possible other incentive is that you may then have an opportunity to become an independent reviewer for rheumatology journals, which is a highly prestigious and interesting task.
Who can participate?
All EMEUNET members are invited to participate. This initiative is not aimed at those of us who are experienced reviewers, particularly those who are already reviewing for top peer-reviewed journals,as these people are less likely to benefit from participating.
How to participate?
We invite EMEUNET members who are interested, to send your application form (attached) to untilApril 14th. Candidates will be selected based on their applicationmerit by members of the Peer Mentoring subgroup and by the EMEUNET Steering Committee.Please note that the number of available places is limited to 5 trainees per group.
You can apply for the following groups with the main area of expertise indicated:
Annals of the Rheumatic Diseases (ARD)
Maxime Dougados:rheumatoid arthritis, clinical epidemiology/clinical trials
Anna Moltó:spondyloarthritis, outcome measures, longitudinal analysis
David Pisetsky:systemic lupus erythematosus, antinuclear autoantibodies, rheumatoid arthritis
Marco Matucci-Cerinic:systemic sclerosis, pathogenesis of scleroderma, lung/vascular involvement
Dirk Elewaut:basic science, immunology, inflammation
Rheumatic and Musculoskeletal Diseases Open (RMD)
Xavier Mariette:Sjögren syndrome, anti-TNF, B-cells, lymphoma and autoimmunity
Daniel Aletaha:early arthritis, diagnosis, therapy, outcomes
Looking forward to hearing from you soon.
EMEUNETPeer Mentoring Subgroup.
EMEUNET Peer Review Mentoring for Rheumatology Journals
with the collaboration of Annals of the Rheumatic Diseases (ARD) and Rheumatic Musculoskeletal Diseases Open (RMD Open)
Please fill in the gaps below and attach a current CV of yours to your application. Your CV should include a list of publications, which may support your application. Application deadline: April 14th
For additional questions on the application process, please contact:
Name (in full, surname first):Email:
Phone:
Name and address of the institution you work at, as well as your contact information:
Scientific background:
Do you have previous scientific experiences that might be related or helpful in reviewing papers for the ARD and RMD Open? Please describe with a maximum of 200 words.
Choice of reviewer group:
Please indicate the group you want to apply for. Applications are possible for only one group.
ARD
Maxime Dougados: rheumatoid arthritis, osteoarthritis, clinical epidemiology and clinical trials
Anna Moltó: spondyloarthritis, outcome measures, longitudinal analysis
Marco Matucci Cerinic: systemic sclerosis, pathogenesis of scleroderma, lung/vascular involvement
David Pisetsky: systemic lupus erythematosus, antinuclear autoantibodies, rheumatoid arthritis
Dirk Elewaut: basic sciences, immunology, inflammation
RMD Open
Xavier Mariette: Sjögren syndrome, anti-TNF, B-cells, lymphoma and autoimmunity
Daniel Aletaha: early arthritis, diagnosis, therapy, outcomes